These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 10094582
1. Leptin resistance in a polygenic, hyperleptinemic animal model of obesity and NIDDM: Psammomys obesus. Walder K, Lewandowski P, Morton G, Sanigorski A, de Silva A, Zimmet P, Collier GR. Int J Obes Relat Metab Disord; 1999 Jan; 23(1):83-9. PubMed ID: 10094582 [Abstract] [Full Text] [Related]
2. Ob (obese) gene expression and leptin levels in Psammomys obesus. Walder K, Willet M, Zimmet P, Collier GR. Biochim Biophys Acta; 1997 Nov 20; 1354(3):272-8. PubMed ID: 9427536 [Abstract] [Full Text] [Related]
3. Impact of obesity and leptin treatment on adipocyte gene expression in Psammomys obesus. Sanigorski A, Cameron-Smith D, Lewandowski P, Walder K, de Silva A, Morton G, Collier GR. J Endocrinol; 2000 Jan 20; 164(1):45-50. PubMed ID: 10607936 [Abstract] [Full Text] [Related]
4. Nicotine treatment decreases food intake and body weight via a leptin-independent pathway in Psammomys obesus. Sanigorski A, Fahey R, Cameron-Smith D, Collier GR. Diabetes Obes Metab; 2002 Sep 20; 4(5):346-50. PubMed ID: 12190999 [Abstract] [Full Text] [Related]
5. Leptin and the development of obesity and diabetes in Psammomys obesus. Collier GR, Walder K, Lewandowski P, Sanigorski A, Zimmet P. Obes Res; 1997 Sep 20; 5(5):455-8. PubMed ID: 9385621 [Abstract] [Full Text] [Related]
6. Dysregulation of leptin in response to fasting in insulin-resistant Psammomys obesus (Israeli sand rats). Walder K, Lee S, Zimmet P, Collier GR. Metabolism; 1998 Jan 20; 47(1):125-8. PubMed ID: 9440491 [Abstract] [Full Text] [Related]
7. Psammomys obesus and the albino rat--two different models of nutritional insulin resistance, representing two different types of human populations. Kalman R, Ziv E, Shafrir E, Bar-On H, Perez R. Lab Anim; 2001 Oct 20; 35(4):346-52. PubMed ID: 11669319 [Abstract] [Full Text] [Related]
8. Profile of dyslipidemia in Psammomys obesus, an animal model of the metabolic syndrome. Walder K, Oakes N, Fahey RP, Cooney G, Zimmet PZ, Collier GR. Endocr Regul; 2002 Mar 20; 36(1):1-8. PubMed ID: 11971745 [Abstract] [Full Text] [Related]
9. The effect of restricting energy intake on diabetes in Psammomys obesus. Barnett M, Collier GR, Zimmet P, O'Dea K. Int J Obes Relat Metab Disord; 1994 Dec 20; 18(12):789-94. PubMed ID: 7894516 [Abstract] [Full Text] [Related]
10. Insulin resistance in the NIDDM model Psammomys obesus in the normoglycaemic, normoinsulinaemic state. Ziv E, Kalman R, Hershkop K, Barash V, Shafrir E, Bar-On H. Diabetologia; 1996 Nov 20; 39(11):1269-75. PubMed ID: 8932991 [Abstract] [Full Text] [Related]
11. Characterization of obesity phenotypes in Psammomys obesus (Israeli sand rats). Walder KR, Fahey RP, Morton GJ, Zimmet PZ, Collier GR. Int J Exp Diabetes Res; 2000 Nov 20; 1(3):177-84. PubMed ID: 11467408 [Abstract] [Full Text] [Related]
13. beta-cell glucotoxicity in the Psammomys obesus model of type 2 diabetes. Leibowitz G, Yuli M, Donath MY, Nesher R, Melloul D, Cerasi E, Gross DJ, Kaiser N. Diabetes; 2001 Feb 20; 50 Suppl 1():S113-7. PubMed ID: 11272167 [Abstract] [Full Text] [Related]
14. Beneficial effects of silibinin against the progression of metabolic syndrome, increased oxidative stress, and liver steatosis in Psammomys obesus, a relevant animal model of human obesity and diabetes. Bouderba S, Sanchez-Martin C, Villanueva GR, Detaille D, Koceïr EA. J Diabetes; 2014 Mar 20; 6(2):184-92. PubMed ID: 23953934 [Abstract] [Full Text] [Related]